Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia
This peptide-based Anti-PCSK9 therapy offers sustained efficacy and safety, representing a promising long-acting alternative for managing hypercholesterolemia.
Authors
- Bibhuti Bhoi
- Jitendra H. Patel (ORCID: https://orcid.org/0009-0005-3703-5703)
- Rajendra S. Chopade
- Hitesh Bhayani
- Tushar M. Patel (ORCID: https://orcid.org/0000-0001-9763-3442)
- Niraj Shah
- Chitrang Trivedi
- Suresh Giri (ORCID: https://orcid.org/0000-0003-0063-5738)
- Vishwanath Pawar
- Sanjay Bandyopadhyay (ORCID: https://orcid.org/0009-0007-0812-2810)
- Rajesh Bahekar (ORCID: https://orcid.org/0000-0002-0105-3134)
- Aman P. Singh (ORCID: https://orcid.org/0000-0002-1886-2624)
- Chintan Patel (ORCID: https://orcid.org/0000-0003-2701-953X)
- Mukul R. Jain (ORCID: https://orcid.org/0000-0001-5730-1435)
- Rajesh Sundar
- Akshyaya Rath
- Vighnesh N. Jadhav
- Niraj M. Sakhrani
- Sandip R. Palode
Institutions
- Zydus Lifesciences Limited (India) (IN)
Publication Details
- Journal
- Vaccines
- Published
- 2025-08-22
- DOI
- https://doi.org/10.3390/vaccines13090889
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01